CHICAGO — In patients being treated for hypertension, those taking a GLP-1 receptor agonist had higher rates of hypotensive events compared with those not taking one, researchers reported at ENDO 2026.“I began to notice multiple patients in clinic who were started on GLP-1s (by me and others) who were complaining of lightheadedness, dizziness and fainting. They had low blood pressure on my examination,” Micah J. Eimer, MD, associate chief medical officer in the division of cardiology at Northwestern Medicine, told Healio. “Hypotension is the most dreaded potential side effect of treating
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Александров: Утро 14 дек, Пт | 0 | 0 | 13-12-2018 |
| 2 | Ozempic tied to improved quality of life in type 2 diabetes, CKD | 0 | 0 | 12-06-2026 |
| 3 | Sleep Apnea May Amplify GLP-1 Survival Benefits in Type 2 Diabetes | 0 | 0 | 23-10-2025 |
| 4 | Taipei 101 at night from a moutain view (Taiwan)Responding to ... | 0 | 0 | 21-02-2025 |
| 5 | [VK] "Союз МС-13": есть стыковка | 0 | 0 | 21-07-2019 |
| 6 | [VK] Auch Amazon will Tausende von Satelliten in eine Umlaufbahn schicken | 0 | 0 | 18-07-2019 |
